Ledrondn (Zoledronic Acid) 4 mg/vial
€18,00
Ledrondn contains zoledronic acid 4 mg — a medication from the bisphosphonate group used for the treatment and prevention of bone tissue disorders. It is used in patients with bone metastases associated with cancer, as well as for the treatment of tumor-induced hypercalcemia. The medicine is administered intravenously as an infusion after reconstitution of the lyophilized powder.
Description
Ledrondn (Zoledronic Acid) 4 mg/vial
Ledrondn is a medicinal product based on zoledronic acid, belonging to the group of bisphosphonates. The medicine is used for the treatment and prevention of bone tissue disorders, particularly in patients with oncological diseases. It helps reduce bone destruction, lowers calcium levels in the blood, and helps prevent fractures and other complications associated with bone damage.
The medicine is administered intravenously as an infusion after reconstitution of the lyophilized powder.
Composition
Active substance:
Zoledronic Acid — 4 mg per vial.
Dosage form
Lyophilized powder for preparation of a solution for intravenous infusion in a vial.
Pharmacological action
Zoledronic acid belongs to third-generation bisphosphonates. It inhibits the activity of osteoclast cells responsible for bone tissue destruction. This helps to:
-
reduce bone resorption
-
increase bone strength
-
reduce the risk of fractures
-
decrease calcium levels in the blood in tumor-related conditions.
Indications for use
The medicine is used for:
-
treatment of tumor-induced hypercalcemia
-
prevention of bone complications in cancer patients
-
treatment of bone metastases
-
treatment of multiple myeloma
-
treatment and prevention of osteoporosis
-
treatment of Paget’s disease of bone.
Method of administration
The medicine is administered only intravenously as an infusion.
The dosage and treatment regimen are determined by a physician depending on the disease and the patient’s condition.
Possible side effects
Possible reactions may include:
-
fever
-
joint and muscle pain
-
weakness or fatigue
-
nausea
-
headache
In rare cases:
-
impaired kidney function
-
decreased calcium levels in the blood
-
osteonecrosis of the jaw.
Contraindications
-
hypersensitivity to zoledronic acid
-
severe renal impairment
-
pregnancy and breastfeeding.
Storage conditions
Store at a temperature below 25°C in a dry place protected from light.
Keep out of reach of children.
Manufacturer
Biozenta Lifesciences Pvt. Ltd.
India.




Reviews
There are no reviews yet.